摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-cyclopropyl-4-{1,4-dioxaspiro[4.5]decan-2-yl}-6-phenylpyrimidine

中文名称
——
中文别名
——
英文名称
2-cyclopropyl-4-{1,4-dioxaspiro[4.5]decan-2-yl}-6-phenylpyrimidine
英文别名
2-Cyclopropyl-4-(1,4-dioxaspiro[4.5]decan-3-yl)-6-phenylpyrimidine;2-cyclopropyl-4-(1,4-dioxaspiro[4.5]decan-3-yl)-6-phenylpyrimidine
2-cyclopropyl-4-{1,4-dioxaspiro[4.5]decan-2-yl}-6-phenylpyrimidine化学式
CAS
——
化学式
C21H24N2O2
mdl
——
分子量
336.434
InChiKey
OYQZZOHKHZHKOP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    44.2
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-cyclopropyl-4-{1,4-dioxaspiro[4.5]decan-2-yl}-6-phenylpyrimidine盐酸 作用下, 以 1,4-二氧六环 为溶剂, 以53%的产率得到1-(2-cyclopropyl-6-phenylpyrimidin-4-yl)ethane-1,2-diol
    参考文献:
    名称:
    DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial Resistance
    摘要:
    Antibiotic resistance is posing a continuous threat to global public health and represents a huge burden for society as a whole. In the past decade, the interference with bacterial quorum sensing (QS) (i.e., cell cell communication) mechanisms has extensively been investigated as a valid therapeutic approach in the pursuit of a next generation of antimicrobials. (S)-4,5-Dihydroxy-2,3-pentanedione, commonly known as (S)-DPD, a small signaling molecule that modulates QS in both Gram-negative and Gram-positive bacteria, is phosphorylated by LsrK, and the resulting phospho-DPD activates QS. We designed and prepared a small library of DPD derivatives, characterized by five different scaffolds, and evaluated their LsrK inhibition in the context of QS interference. SAR studies highlighted the pyrazole moiety as an essential structural element for LsrK inhibition. Particularly, four compounds were found to be micromolar LsrK inhibitors (IC50 ranging between 100 mu M and 500 mu M) encouraging further exploration of novel analogues as potential new antimicrobials.
    DOI:
    10.1021/acs.jmedchem.9b00025
  • 作为产物:
    描述:
    苯甲酰氯 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodidesodium carbonate decahydrate三乙胺 作用下, 以 四氢呋喃 为溶剂, 生成 2-cyclopropyl-4-{1,4-dioxaspiro[4.5]decan-2-yl}-6-phenylpyrimidine
    参考文献:
    名称:
    DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial Resistance
    摘要:
    Antibiotic resistance is posing a continuous threat to global public health and represents a huge burden for society as a whole. In the past decade, the interference with bacterial quorum sensing (QS) (i.e., cell cell communication) mechanisms has extensively been investigated as a valid therapeutic approach in the pursuit of a next generation of antimicrobials. (S)-4,5-Dihydroxy-2,3-pentanedione, commonly known as (S)-DPD, a small signaling molecule that modulates QS in both Gram-negative and Gram-positive bacteria, is phosphorylated by LsrK, and the resulting phospho-DPD activates QS. We designed and prepared a small library of DPD derivatives, characterized by five different scaffolds, and evaluated their LsrK inhibition in the context of QS interference. SAR studies highlighted the pyrazole moiety as an essential structural element for LsrK inhibition. Particularly, four compounds were found to be micromolar LsrK inhibitors (IC50 ranging between 100 mu M and 500 mu M) encouraging further exploration of novel analogues as potential new antimicrobials.
    DOI:
    10.1021/acs.jmedchem.9b00025
点击查看最新优质反应信息

文献信息

  • DPD-Inspired Discovery of Novel LsrK Kinase Inhibitors: An Opportunity To Fight Antimicrobial Resistance
    作者:Silvia Stotani、Viviana Gatta、Prasanthi Medarametla、Mohan Padmanaban、Anna Karawajczyk、Fabrizio Giordanetto、Päivi Tammela、Tuomo Laitinen、Antti Poso、Dimitros Tzalis、Simona Collina
    DOI:10.1021/acs.jmedchem.9b00025
    日期:2019.3.14
    Antibiotic resistance is posing a continuous threat to global public health and represents a huge burden for society as a whole. In the past decade, the interference with bacterial quorum sensing (QS) (i.e., cell cell communication) mechanisms has extensively been investigated as a valid therapeutic approach in the pursuit of a next generation of antimicrobials. (S)-4,5-Dihydroxy-2,3-pentanedione, commonly known as (S)-DPD, a small signaling molecule that modulates QS in both Gram-negative and Gram-positive bacteria, is phosphorylated by LsrK, and the resulting phospho-DPD activates QS. We designed and prepared a small library of DPD derivatives, characterized by five different scaffolds, and evaluated their LsrK inhibition in the context of QS interference. SAR studies highlighted the pyrazole moiety as an essential structural element for LsrK inhibition. Particularly, four compounds were found to be micromolar LsrK inhibitors (IC50 ranging between 100 mu M and 500 mu M) encouraging further exploration of novel analogues as potential new antimicrobials.
查看更多